News Mar 06, 2023 Mindmaze launches revolutionary device to improve hand recovery after stroke MindMaze, a Vaud-based worldwide leader in AI-powered digital neurotherapeutics, has released its own proprietary medical device called Izar in t...
News Feb 28, 2023 Terapet raises CHF 2.3 million for its next-generation cancer treatment technology Geneva-based medtech Terapet has announced the closing of its first Pre-Series A investment round in the amount of CHF 2.3 million.
News Feb 13, 2023 Hôpital de La Tour will invest CHF 750 million to create a health campus in Geneva Leading private healthcare facility Hôpital de la Tour has entered into a CHF 750 million agreement to create a major health campus project to pr...
News Jan 30, 2023 Alithea Genomics and CHUV to help make immunotherapy treatments more targeted Dutch-Swiss consortium MAINLINE, consisting of PamGene International B.V., Alithea Genomics and CHUV, received a Eurostars grant of EUR 1 million...
News Jan 18, 2023 The University of Fribourg unveils bioinspired nanosensors for early detection of cancer Scientists from the University of Fribourg have developed bioinspired nanosensors for rapid, sensitive, and specific detection of cancer-derived ...
News Jan 18, 2023 Calciscon enters Eurostars project to improve patient care worldwide Calciscon, together with Amsterdam University Medical Centers and ADMESY, have signed a collaborative agreement for the development of a laborato...
News Jan 16, 2023 Geneva start-up STALICLA signs exclusive in-licensing agreement with Novartis STALICLA has acquired global rights for Novartis' drug candidate mavoglurant, a treatment for substance-use disorders and neurodevelopmental diso...
News Dec 05, 2022 CSEM will establish its Digital Health Center in Bern The CSEM will establish the Digital Health Center, a new research center for digital health, on the campus of the Inselspital in Bern.
News Nov 29, 2022 CHUV, CERN and THERYQ join forces for a world first in cancer radiotherapy CHUV, CERN and THERYQ will develop a revolutionary FLASH radiotherapy device to treat cancers resistant to conventional treatments.
News Nov 23, 2022 Geneva biopharma ObsEva sells its Ebopiprant license for up to USD 113 million Women's and reproductive health specialist ObsEva has announced the sale of its license for ebopiprant to California-based biotech company Xoma f...
News Nov 16, 2022 The HEIA-FR drives innovation through collaboration Located in the heart of Western Switzerland, the HEIA-FR collaborates closely with economic and industrial partners through its ten applied resea...
News Nov 15, 2022 Comet, Neuria and PMF-System win the Fribourg Innovation Award The canton of Fribourg has distinguished its most innovative companies. The Business Award went to Comet, the Start-up Award went to Neuria, and ...
News Nov 07, 2022 Idiap and InflamAlps partner up to accelerate antibiotic research using artificial intelligence The result of a partnership between Valais-based pharma company InflamAlps and the Idiap institute, the ABRoad project aims to accelerate the sel...
News Oct 17, 2022 1STMC: Switzerland’s first translational medicine conference Organized by sitem-insel, the 1st Swiss Translational Medicine Conference will take place in Bern on 27 October 2022.
News Oct 06, 2022 The Fongit Innovation Fund rewards three deeptech start-ups The Fongit has announced the latest beneficiaries of the FIF. Geneva-based start-ups EBAMed and Terapet have been awarded a seed loan of CHF 100,...
News Sep 26, 2022 Western Switzerland start-ups celebrated at the TOP 100 Swiss Startups Award Just behind Zurich, start-ups from the cantons of Vaud, Bern Geneva and Valais led the twelfth edition of the TOP 100 Swiss Startups Award.
News Sep 19, 2022 OnlineDoctor wins Health-i Award OnlineDoctor has won the Health-i Award presented by Techniker Krankenkasse and the Handelsblatt Media Group in the Companies category. With this...
News Aug 16, 2022 OnlineDoctor puts electronic prescriptions to the test For the first time, dermatologists can issue electronic prescriptions for their patients via the OnlineDoctor platform. For this, the St.Gallen p...